Breast Cancer Research and Treatment

, Volume 125, Issue 2, pp 599–600 | Cite as

Need for clarification of results in the recent meta-analysis about SULT1A1 codon 213 polymorphism and breast cancer risk

  • Pei-Hua Lu
  • Mu-Xin Wei
  • Chen Li
  • Xiao Liu
  • Min-Bin Chen
Letter to the Editor


Breast Cancer Breast Cancer Risk Methodological Issue Comparison Model Breast Cancer Case 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors are fully responsible for all the content and editorial decisions and have not received any financial support or other form of remuneration related to the development of this article.


  1. 1.
    Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L (2010) The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0953-5
  2. 2.
    The MARIE-GENICA Consortium (2010) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463–474Google Scholar
  3. 3.
    Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A (2005) Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenet Genomics 15:749–752CrossRefPubMedGoogle Scholar
  4. 4.
    Wang Z, Fu Y, Tang C, Lu S, Chu WM (2010) SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8, 454 cases and 11, 800 controls. Breast Cancer Res Treat 122:193–198CrossRefPubMedGoogle Scholar
  5. 5.
    Economopoulos KP, Sergentanis TN (2010) Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: convergence and divergence of the two recent meta-analyses. Breast Cancer Res Treat. doi: 10.1007/s10549-010-1143-1
  6. 6.
    Economopoulos KP, Sergentanis TN (2010) Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis. Breast Cancer Res Treat 124:293–294CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Pei-Hua Lu
    • 1
  • Mu-Xin Wei
    • 2
  • Chen Li
    • 3
  • Xiao Liu
    • 1
  • Min-Bin Chen
    • 4
  1. 1.Department of General SurgeryWuxi People’s Hospital of Nanjing Medical UniversityWuxiChina
  2. 2.Department of Traditional Chinese MedicineFirst Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  3. 3.Department of GastroenterologyXuzhou Chinese Medicine Hospital Affiliated to Nanjing University of Chinese MedicineXuzhouChina
  4. 4.Department of OncologyKunshan People’s Hospital Affiliated to Jiangsu UniversityKunshanChina

Personalised recommendations